Data from the Spanish Clinical Trials Register reveal the commitment of the pharmaceutical industry, which finances 88% of trials with paediatric patients. Incentives for innovation are […]

Oncology is one of the key issues on the health agenda that Spain will take to the Presidency of the Council of the European Union in […]

Farmaindustria’s Director of Access, Isabel Pineros, analyses the current challenges of access to therapeutic innovation at the Spanish Summit against Cancer, organised by Gepac “We must […]

2021 closes with the best R&D investment figures ever: the pharmaceutical industry allocates 1,267 million euros to both private and public projects. Source: elespanol.com Investing in […]

The project is called Borders should no longer be barriers and has been promoted by Efpia and the European Good Clinical Practice Forum, in collaboration with […]

25% of the studies authorised last year are already for orphan drugs to combat rare diseases 86% of trials are driven by the pharmaceutical industry Javier […]

The pharmaceutical industry in Spain has a total of 103 production plants, a figure that rises to 173 when active ingredients and veterinary medicines are added […]

The figure reached in 2021 is 9% higher than in 2020, when, despite the pandemic, the sector achieved the second best record in its history up […]

A Dutch team has developed a cell therapy for metastatic melanoma that improves on the current standard. Source: elespanol.com Researchers in the Netherlands and Denmark have […]

Representatives of scientific societies, public administrations, researchers and pharmaceutical companies make up the group. Clinical research at this level of care has a great opportunity for […]

Source: actasanitaria.com This report outlines the medicines already assessed by the Spanish Agency for Medicines and Health Products (AEMPS), which are considered to be of greatest interest […]